Relationship between papillary thyroid cancer and Hashimoto’s disease

dc.contributor.authorErdoğmuş, Sema
dc.contributor.authorTakır, Mümtaz
dc.contributor.authorKöstek, Osman
dc.contributor.authorŞenol, Serkan
dc.contributor.authorMutlu, Hasan Hüseyin
dc.date.accessioned2025-05-10T15:24:33Z
dc.date.issued2016
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractThyroid cancer is the most frequent type of endocrine system cancers. Papillary thyroid carcinomas (PTCs) which have favourable prognosis and account for 80% of thyroid cancer. Hashimoto thyroiditis is the most common cause of hypothroidism in the world. Previous studies demonstrated that chronic inflammation might lead to development of cancer. This paper aimed to determine possible relationship between PTC and Hashimoto’s thyroditis. Pathology archives of the patients who had been followed up with the diagnosis of thyroid papillary tumors by clinics of endocrinology, and family medicine, and undergone thyroidectomy between January 2008 and March 2015 were retrospectively reviewed. Patients under 18 years of age were not included in the study the incidence of Hashimoto thyroiditis which accompanied papillary thyroid cancer was retrospectively investigated. PTC and healthy control groups with their pathologic and laboratory data were included in the study. A total of 87 PTC and 87 healthy subjects were enrolled. Of all participants, mean age was 47±15 years and male to female ratio was approximately 1:8. in both groups. Family histories regarding thyroid carcinomas, nonthyroidal malignancies, Hashimoto thyroiditis and systematic autoimmune disease revealed similar incidence rates in both groups (p>0.05, for all). Although PTC patients had higher TSH and fT3 median values, while fT4, anti-TPO, anti-Tg values were similar. Finally, association between PTC and Hashimoto thyroiditis was analyzed, and frequency of Hashimoto thyroiditis in PTC patients, and the control group was comparable. The distribution of Hashimoto thyroiditis in patients with PTC was similar to those of the control group. © 2016, Logos Medical Publishing. All rights reserved.
dc.identifier.doi10.5222/MMJ.2016.186
dc.identifier.endpage191
dc.identifier.issn2149-2042
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85044129291
dc.identifier.scopusqualityQ2
dc.identifier.startpage186
dc.identifier.trdizinid353316
dc.identifier.urihttps://doi.org/10.5222/MMJ.2016.186
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/353316
dc.identifier.urihttps://hdl.handle.net/20.500.14730/6777
dc.identifier.volume31
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isotr
dc.publisherLogos Medical Publishing
dc.relation.ispartofMedeniyet Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250302
dc.subjectHashimoto’s thyroiditis; Papillary thyroid carcinoma; Systemic autoimmune diseases
dc.titleRelationship between papillary thyroid cancer and Hashimoto’s disease
dc.title.alternativePapiller tiroid karsinomu ile hashimoto hastalığı arasındaki ilişki
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
6777.pdf
Boyut:
390.66 KB
Biçim:
Adobe Portable Document Format